Work

A first in human, dose escalation trial of MSC2363318A – a dual p70S6K/Akt inhibitor, for patients with advanced malignancies

Year: 2015

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdv094.1

Authors: A.M. Tsimberidou, C. Verschraegen, G. Heestand, R. Kaleta, J. Scheuenpflug, B. Huck, A. Weise, R. Kurzrock

Institutions: The University of Texas MD Anderson Cancer Center, University of Vermont, University of California San Diego, EMD Serono, Inc. (United States)

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W1980830282

FWCI: 0.145

Cites:

Cited by: 5

Related to: 10